BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27992034)

  • 1. Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.
    Burgos PF; Luna Filho B; Costa FA; Bombig MT; Souza D; Bianco HT; Oliveira Filho JA; Izar MC; Fonseca FA; Póvoa R
    Arq Bras Cardiol; 2017 Jan; 108(1):47-52. PubMed ID: 27992034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM; van de Poll SWE; de Groot-de Laat LE; Kardys I; Zijlstra F; van Dalen BM
    Clin Cardiol; 2020 May; 43(5):483-490. PubMed ID: 31990994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D; Xu JZ; Zhang W; Chen Y; Li J; An Y; Bian R; Wang JG
    Am J Hypertens; 2020 Sep; 33(9):831-836. PubMed ID: 32484222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic diagnosis of the left ventricular hypertrophy in patients with left bundle branch block: is it necessary to verify old criteria?
    Baranowski R; Małek L; Prokopowicz D; Spiewak M; Miśko J
    Cardiol J; 2012; 19(6):591-6. PubMed ID: 23224921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the electrocardiogram RV
    Yang P; Ge Z; Gao J; Liu X; Xu M; Ke H
    J Clin Hypertens (Greenwich); 2023 Jul; 25(7):638-646. PubMed ID: 37378534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men].
    Zeng XZ; Liu DP; He Q; Guo HL; Fang F; Liu DG; Dong R; Zeng HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):56-8. PubMed ID: 19671355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of right bundle branch block on electrocardiographic amplitudes, including combined voltage criteria used for the detection of left ventricular hypertrophy.
    Chan PG; Logue M; Kligfield P
    Ann Noninvasive Electrocardiol; 2006 Jul; 11(3):230-6. PubMed ID: 16846437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study.
    Rodrigues SL; Angelo LC; Baldo MP; Dantas EM; Barcelos AM; Pereira AC; Krieger JE; Mill JG
    Clin Res Cardiol; 2013 Sep; 102(9):653-9. PubMed ID: 23660930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z; Song J; Cheng L; Li S; Lu Q; Zhang Y; Lin X; Liu D
    PLoS One; 2021; 16(1):e0246305. PubMed ID: 33513186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
    Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.